Publications

Hines MR, Knight TE, McNerney KO, Leick MB, Jain T, Ahmed S, Frigault MJ, Hill JA, Jain MD, Johnson WT, Lin Y, Mahadeo KM, Maron GM, Marsh RA, Neelapu SS, Nikiforow S, Ombrello AK, Shah NN, Talleur AC, Turicek D, Vatsayan A, Wong SW, Maus MV, Komanduri KV, Berliner N, Henter JI, Perales MA, Frey NV, Teachey DT, Frank MJ, Shah NN. Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>. Transplantation and cellular therapy. 2025. PMID: 41067707

Fergus KB, Newberg J, Greenstein R, Fejerman L, Carvajal-Carmona L, Collisson E, Dixit N, Frampton G, Huang FW, Neuhausen SL, Ziv E. Association between ancestry and tumor somatic mutations in a large national cohort of women with breast cancer. NPJ breast cancer. 2025. PMID: 41162424

Lai TYY, Arias L, Cheung CMG, Couturier A, Liu W, O'Leary OE, Rafijah N, Shah N, Yoon YH, Patel S, POYANG Study investigators. POYANG: A phase III randomized clinical trial of faricimab for choroidal neovascularization secondary to pathologic myopia: study design and rationale. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2025. PMID: 41152620

Krasnow NA, Jayaraj M, Salans M, Kuwahara K, Zhou MH, Fisch S, Boreta L, Braunstein SE, Aghi MK, Batra-Sharma H, Majure M, Chien J, Rugo HS, Morshed RA, Vasudevan HN, Melisko ME, Huppert LA. Evaluating survival trends over time in patients with metastatic breast cancer and brain metastases: a single center retrospective cohort study. Breast cancer research : BCR. 2025. PMID: 41153023

Wang H, Ge Y, Shao W, Xiong X, Li G, Li N, Hu X, Chen G, Dong K, Ai W, Yu Z, Zheng Z, Wang C, Yao F, Cao X, Li S, Zhao J, Ke W, Tao C, Hou Y, Petrozza A, Fang G. Yttrium oxide engineered substrate enables improved durability for perovskite solar cells. Nature communications. 2025. PMID: 41152230

Jindal T, Jiang CY, Alhalabi O, Davidsohn M, Freeman D, Epstein IY, Bakaloudi DR, Talukder R, Nizam A, Nguyen CB, Oh E, Tsung I, Glover MJ, Khaki AR, Taylor AK, Jaime-Casas S, Jang A, Lemke E, Pywell C, Evans ST, Shin D, Bilen MA, Basu A, Kilari D, Tripathi A, Brown J, Emamekhoo H, Davis NB, Shah S, Gupta S, Grivas P, Bellmunt J, Alva A, Campbell MT, Koshkin VS. Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study. Urologic oncology. 2025. PMID: 41152111

Reig M, Sanduzzi-Zamparelli M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Díaz A, Llarch N, Iserte G, Mollà M, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Yanagihara TK, Ayuso C, Torres F, Bruix J. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update. Journal of hepatology. 2025. PMID: 41151697

Praw SS, Gigliotti BJ, Tessnow A, Kang H, Margulies DJ. Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid : official journal of the American Thyroid Association. 2025. PMID: 41173539

DeBoer RJ, Uwamahoro P, Ndoli DA, Rugengamanzi E, Mulindabigwi A, Bigirimana JB, Musafiri T, Slater SE, Van Loon K, Sudore RL, Anderson WG, Sanders JJ, Cubaka VK. Adaptation of a serious illness communication training intervention for the Rwandan context. Journal of pain and symptom management. 2025. PMID: 41135916

Goudy L, Ha A, Borah AA, Umhoefer JM, Chow L, Tran C, Winters A, Talbot A, Hernandez R, Li Z, Subramanya S, Arab A, Kale N, Lee JHJ, Muldoon JJ, Liu C, Schmidt R, Santangelo P, Carnevale J, Eyquem J, Shy BR, Marson A, Gilbert LA. Integrated epigenetic and genetic programming of primary human T cells. Nature biotechnology. 2025. PMID: 41120666

Suresh A, Pan D, Lipof J, Kumar A, Arora S, Sayre P, Wolf J, Martin T, Chari A, Chung A. How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy? Immunotherapy. 2025. PMID: 41104991

Johnston S, Martin M, O'Shaughnessy J, Hegg R, Tolaney SM, Guarneri V, Del Mastro L, Campone M, Sohn J, Boyle F, Cortes J, Rugo HS, Goetz MP, Hamilton EP, Huang CS, Senkus E, Cicin I, Testa L, Neven P, Huober J, Shao Z, Wei R, Munoz M, San Antonio B, Shahir A, Rastogi P, Harbeck N. Overall survival with abemaciclib in early breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2025. PMID: 41110697

Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof Warner A, Blackwell S, Calabrese C, Cho TA, Dougan M, Ferreira M, Funchain P, Herndon J, Johnson DB, Kennedy R, Kheterpal M, Khouri M, Lechner MG, Lim AM, Markova A, Meara A, Overton L, Perdigoto AL, Sachithanandan N, Sharon E, Spain L, Tsai K, Yarchoan M, Reynolds KL, Shariff A. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. Journal for immunotherapy of cancer. 2025. PMID: 41093625

Chowdhury S, Gasper C, Lazar AA, Allaire K, Darragh TM, Fong L, Palefsky JM. Expression of Programmed Death-Ligand 1 and Programmed Cell Death-1 Across the Anal Neoplasia Disease Continuum and Association With Survival in Anal Cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2025. PMID: 41106476

Woodard GA, Kramer RJ, Blakely CM. Neoadjuvant Tyrosine Kinase Inhibitors. Thoracic surgery clinics. 2025. PMID: 41260725

Avigan ZM, Catlett J, Bodnar S, Pan D, Aleman A, Sheng T, Moshier E, Rossi AC, Richard S, Kaur G, Richter J, Sanchez LJ, Rodriguez C, Cho HJ, Hussein S, Salib C, Silverman LR, Jagannath S, Parekh S, Thibaud S. Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025. PMID: 40801897

Jaishankar P, Correy GJ, Matsui Y, Togo T, Rachman MM, Stevens MGV, Hantz ER, Zheng J, Diolaiti ME, Montano M, Taha TY, Rosecrans J, Pampel J, Krogan NJ, Shoichet BK, Ashworth A, Ott M, Fraser JS, Renslo AR. Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo. bioRxiv : the preprint server for biology. 2025. PMID: 41279160

Ebadi M, Fan X, Schoch G, Gooley T, Rashidi A, Smith SD, Shadman M, Holmberg L, Ujjani C, Poh C, Raghunathan V, Ali N, Vo PT, Manjappa S, Menon M, Di M, Lynch R, Ho C, Till BG, Ermoian R, Gopal AK, Tseng YD. Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma. Clinical oncology (Royal College of Radiologists (Great Britain)). 2025. PMID: 41172559

Finn RS, Rugo HS, Cortes J, Loibl S, Foley G, Gauthier E, Wang Y, Kim S, Anders L, Slamon DJ. A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer. Targeted oncology. 2025. PMID: 41087648

Gelmon K, Villarreal-Garza C, Aubel D, S Rugo H, Maués J, Travado L, Van Meerveld M, C W Chidebe R, Patel B, Attfield G, Lewis A, Cardoso F. Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (goal 3). Breast (Edinburgh, Scotland). 2025. PMID: 41298008